Concepedia

Kelly Frazier

KF

Statistics

Publications

5

Citations

464

H-Index

5

Active since

1999

Affiliations

University of Georgia(Current)

Kelly Frazier is an author at University of Georgia specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

1999–2011

5

Publications

5

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 251 citations · Full text

, , +13

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 135 citations · Full text

, , +13

162 cases of aldicarb intoxication in Georgia domestic animals from 1988-1998.

Kelly Frazier, Gordon A. Hullinger, Melissa T. Hines et al. · PubMed · 1999 · 36 citations

, , +7

Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors

Matthew T. Burger, Mark Knapp, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2010 · 30 citations · Full text

, , +17

Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases

Kelly Frazier, Elisa M. Jazan, Christopher M. McBride et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 12 citations · Full text

, , +16

1–5 of 5